{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-008671","form_type":"8-K","ticker":null,"cik":"0001792581","company_name":"Kiromic Biopharma, Inc.","filed_at":"2025-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.888256+00:00","generated_at":"2026-05-24T08:58:01.035692+00:00","sec_items":["1.03","5.03"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Kiromic BioPharma files for Chapter 7 bankruptcy; board and officers depart","bullets":["Filed voluntary Chapter 7 bankruptcy petition on March 21, 2025 in Delaware Bankruptcy Court.","Chapter 7 trustee to be appointed to administer and possibly liquidate company assets.","All four board members (Pietro Bersani, Michael Nagel, Mike Catlin, Pamela Misajon) resigned effective immediately.","Terminated CFO Brian Hungerford, COO Leonardo Mirandola, and Chief of Staff Scott Dahlbeck on March 21, 2025.","Board has zero members following resignations; control passes to trustee."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-008671","json":"https://secwatch.observer/filing/0001437749-25-008671.json","markdown":"https://secwatch.observer/filing/0001437749-25-008671.md","text":"https://secwatch.observer/filing/0001437749-25-008671.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/0001437749-25-008671-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/krbp20250321_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T08:58:01.035692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"30f79bfd69548525af21c25274f7f6269da2f30d","claim":"Kiromic Biopharma, Inc. entered chapter 7 in United States Bankruptcy Court for the District of Delaware (petition 2025-03-21).","evidence_excerpt":"On March 21, 2025, Kiromic BioPharma, Inc. (the \"Company\") filed a voluntary petition for relief (the \"Bankruptcy Filing\") under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §101 et seq. (the \"Bankruptcy Code\").","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/0001437749-25-008671-index.htm","confidence":1.0,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 7"},{"label":"Court","value":"United States Bankruptcy Court for the District of Delaware"},{"label":"Petition","value":"2025-03-21"}],"fact_type":"distress_event"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}